Organism name | Lycopersicon esculentum |
---|---|
Genus | Lycopersicon |
Family | Solanaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Solanum lycopersicum |
---|---|
Linked NCBI taxonomy ID | 4081 |
Linked level | species |
Family in NCBI taxonomy | Solanaceae |
---|---|
ID | 4070 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005374
![]() |
Quercetin
|
CHEMBL82242
CHEMBL479232 CHEMBL1437696 |
C012526
|
14 / 2 / 2 | 2 / 1 | No. 2 | No. 15 |
![]() |
C00006900
![]() |
Petanin
/ Petunidin 3-O-[6-O-(4-O-(E)-p-coumaroyl-O-alpha-rhamnopyranosyl)-beta-glucopyranoside]-5-O-beta-glucopyranoside |
No. 7 | No. 15 |
![]() |
||||
C00000998
![]() |
Prunin
/ Naringenin 7-O-beta-D-glucoside / 5,7,4'-Trihydroxyflavanone 7-O-beta-D-glucopyranoside |
CHEMBL469654
CHEMBL526845 |
1 / 2 / 0 | No. 12 | No. 14 |
![]() |
||
C00002262
![]() |
alpha-Solanine
|
CHEMBL1212997
CHEMBL1392894 CHEMBL1975187 CHEMBL2357167 |
D012992
|
13 / 10 / 12 | No. 17 | No. 11 |
![]() |
|
C00030216
![]() |
Esculeoside A
|
CHEMBL1269162
|
No. 21 | No. 11 |
![]() |
|||
C00002268
![]() |
Tomatine
|
CHEMBL525778
CHEMBL2007040 |
D014053
|
No. 21 | No. 11 |
![]() |
||
C00003765
![]() |
alpha-Carotene
|
No. 26 | No. 59 |
![]() |
||||
C00000034
![]() |
GA34
/ Gibberellin A34 |
No. 40 | No. 41 |
![]() |
||||
C00000029
![]() |
GA29
/ Gibberellin A29 |
No. 40 | No. 41 |
![]() |
||||
C00000051
![]() |
GA51
/ Gibberellin A51 |
No. 40 | No. 41 |
![]() |
||||
C00000081
![]() |
GA81
/ Gibberellin A81 |
No. 40 | No. 41 |
![]() |
||||
C00000004
![]() |
GA4
/ Gibberellin A4 |
No. 40 | No. 41 |
![]() |
||||
C00007335
![]() |
24-Epityphasterol
|
No. 68 | No. 11 |
![]() |
||||
C00007334
![]() |
24-Epiteasterone
|
No. 68 | No. 11 |
![]() |
||||
C00004565
![]() |
Kaempferol
/ Nimbecetin / Rhamnolutein / Pelargidenolon / 5,7,4'-Trihydroxyflavonol / 3,5,7,4'-Tetrahydroxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL150
|
C006552
|
76 / 69 / 87 | 86 / 8 | No. 71 | No. 15 |
![]() |
C00007233
![]() |
Isosalipurpol
/ Chalconaringenin / Naringenin chalcone / trans-2',4,4',6'-Tetrahydroxychalcone / (2E)- 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-2-Propen-1-one |
CHEMBL338066
|
12 / 20 / 21 | No. 92 | No. 13 |
![]() |
||
C00022905
![]() |
Lycophyll
/ psi,psi-Carotene-16,16'-diol |
No. 97 | No. 59 |
![]() |
||||
C00022937
![]() |
Lycopene 1,2-epoxide
/ 1,2-Epoxy-1,2-dihydro-psi,psi-carotene |
No. 97 | No. 59 |
![]() |
||||
C00003778
![]() |
Lycoxanthin
|
No. 97 | No. 59 |
![]() |
||||
C00022938
![]() |
1,2-Epoxy-1,2,7,7',8,8'-hexahydro-psi,psi-carotene
|
No. 97 | No. 59 |
![]() |
||||
C00000911
![]() |
Lycopene
/ all-trans-Lycopene |
CHEMBL501174
CHEMBL1984187 |
C015329
|
6 / 13 / 13 | 84 / 13 | No. 97 | No. 59 |
![]() |
C00001250
![]() |
Hentriacontane
|
CHEMBL257490
|
C049203
|
No. 115 |
![]() |
|||
C00022936
![]() |
1',2'-Epoxy-1',2'-dihydro-epsilon,psi-carotene
|
No. 131 | No. 59 |
![]() |
||||
C00000926
![]() |
gamma-Carotene
|
No. 131 | No. 59 |
![]() |
||||
C00022935
![]() |
1',2'-Epoxy-1',2'-dihydro-beta,psi-carotene
|
No. 131 | No. 59 |
![]() |
||||
C00002267
![]() |
Tomatidine
|
CHEMBL365417
CHEMBL1476096 CHEMBL1622974 CHEMBL1976775 CHEMBL1998601 CHEMBL2165711 |
C003677
|
10 / 15 / 14 | No. 171 | No. 11 |
![]() |
|
C00000298
![]() |
GA97
/ Gibberellin A97 |
No. 187 | No. 41 |
![]() |
||||
C00000053
![]() |
GA53
/ Gibberellin A53 |
No. 187 | No. 41 |
![]() |
||||
C00022165
![]() |
4,8,12-Trimethyl-1,3E,7E,11-tridecatetraene
/ (E,E)-4,8,12-Trimethyl-1,3,7,11-tridecatetraene |
No. 404 | No. 38 |
![]() |
||||
C00000816
![]() |
beta-Pinene
|
CHEMBL501351
|
C010789
|
No. 476 | No. 35 |
![]() |
||
C00000805
![]() |
alpha-Pinene
|
CHEMBL442565
|
C005451
|
3 / 3 / 2 | 0 / 1 | No. 476 | No. 35 |
![]() |
C00003110
![]() |
Caryophyllene
/ (E)-Caryophyllene / beta-Caryophyllene / (-)-(E)-Caryophyllene / (E)-beta-Caryophyllene |
CHEMBL445740
CHEMBL448700 |
2 / 3 / 7 | No. 478 | No. 38 |
![]() |
||
C00023105
![]() |
6'-Apo-psi,psi-carotenal
|
No. 575 |
![]() |
|||||
C00000107
![]() |
IAN
/ Indole-3-acetonitrile |
CHEMBL1812654
|
C016516
|
No. 710 | No. 4 |
![]() |
||
C00001434
![]() |
Tryptamine
/ beta-(3-Indolyl)ethylamine |
CHEMBL6640
|
C030820
|
20 / 5 / 7 | 6 / 2 | No. 710 | No. 4 |
![]() |
C00001283
![]() |
Falcarindiol
|
CHEMBL69018
CHEMBL1094112 |
C034379
|
3 / 0 / 0 | No. 940 | No. 69 |
![]() |
|
C00000096
![]() |
9-Ribosyl-trans-zeatin
/ Zeatin-9-beta-D-ribofuranoside |
No. 989 |
![]() |
|||||
C00003779
![]() |
Mutatochrome
/ beta-carotene 5,8-epoxide |
C001792
|
No. 1206 | No. 59 |
![]() |
|||
C00000575
![]() |
Bergaptan
|
CHEMBL24171
|
C022909
|
22 / 22 / 17 | 0 / 3 | No. 1282 | No. 25 |
![]() |
C00003147
![]() |
Humulene
/ alpha-Caryophyllene / (+/-)-alpha-Humulene |
CHEMBL251280
|
C042686
|
No. 1421 | No. 38 |
![]() |
||
C00000100
![]() |
IAA
/ Indole-3-acetic acid |
CHEMBL82411
|
C030737
|
3 / 0 / 0 | 2 / 1 | No. 1432 | No. 4 |
![]() |
C00007571
![]() |
IPA
/ Indolepyruvate |
CHEMBL485012
|
16 / 20 / 16 | No. 1432 | No. 4 |
![]() |
||
C00000134
![]() |
(s)-(+)-Abscisic acid
/ 2,4-Pentadienoic acid |
CHEMBL288040
CHEMBL379808 CHEMBL1318134 CHEMBL1469719 CHEMBL1741460 CHEMBL1965138 |
D000040
|
10 / 9 / 10 | No. 1435 | No. 38 |
![]() |
|
C00010872
![]() |
beta-Phellandrene
/ (+/-)-beta-Phellandrene |
CHEMBL444254
|
C058582
|
No. 1898 | No. 35 |
![]() |
||
C00001429
![]() |
Serotonin
/ Enteramin / Enteramine / DS substance / Thrombotonin / Thrombocytin / 5-Hydroxytryptamine |
CHEMBL39
CHEMBL1628597 |
D012701
|
78 / 35 / 22 | 32 / 40 | No. 1910 | No. 4 |
![]() |
C00000104
![]() |
5-Hydroxyindole-3-acetic acid
|
CHEMBL395915
|
D006897
|
22 / 32 / 22 | 0 / 8 | No. 1910 | No. 4 |
![]() |
C00030767
![]() |
Methyl salicylate
|
CHEMBL108545
|
C033069
|
92 / 52 / 46 | 29 / 3 | No. 2169 |
![]() |
|
C00022939
![]() |
Phytoene 1,2-epoxide
/ 1,2-Epoxy-1,2,7,7',8,8',11,11',12,12'-decahydro-psi,psi-carotene |
No. 2614 | No. 59 |
![]() |
||||
C00029452
![]() |
2-Carene
|
No. 2690 | No. 35 |
![]() |
||||
C00000091
![]() |
trans-Zeatin
|
CHEMBL525239
|
D015026
|
2 / 3 / 2 | 0 / 1 | No. 2879 |
![]() |
|
C00000093
![]() |
Dihydrozeatin
|
No. 2879 |
![]() |
|||||
C00000094
![]() |
2iP
/ N6-(delta2-Isopentenyl)adenine |
CHEMBL476189
|
C001478
|
5 / 2 / 3 | 18 / 0 | No. 2879 |
![]() |
|
C00000117
![]() |
Indole-3-acetyl-L-aspartic acid
|
C026984
|
No. 2986 |
![]() |
||||
C00026660
![]() |
Lycoperodine 1
/ 3-Carboxy-1,2,3,4-tetrahydro-beta-carboline / (-)-3-Carboxy-1,2,3,4-tetrahydro-beta-carboline |
CHEMBL149177
CHEMBL155546 CHEMBL1915148 |
1 / 2 / 2 | No. 3209 |
![]() |
|||
C00001151
![]() |
Sucrose
/ (+)-Sucrose |
CHEMBL253582
CHEMBL1976550 |
D013395
|
1 / 0 / 0 | 4 / 10 | No. 3949 |
![]() |
|
C00007452
![]() |
Sucrose 6-phosphate
|
C535046
|
No. 3949 |
![]() |
||||
C00000353
![]() |
(Z)-3-Hexenal
|
No. 4004 |
![]() |
|||||
C00000092
![]() |
N6-Benzyladenine
|
CHEMBL228862
|
C000142
|
13 / 16 / 15 | No. 4069 |
![]() |
||
C00000101
![]() |
IAA methyl ester
/ Methyl indole-3-acetate |
No. 4225 |
![]() |
|||||
C00040805
![]() |
25-Hydroxyvitamin D3
|
CHEMBL15596
CHEMBL1040 CHEMBL80554 CHEMBL1222 CHEMBL1599212 |
D002112
|
7 / 12 / 7 | 3 / 5 | No. 4779 |
![]() |
|
C00041217
![]() |
Vitamin D3
/ Cholecalciferol |
CHEMBL1042
CHEMBL432780 CHEMBL1236645 CHEMBL1354424 CHEMBL1365250 CHEMBL1456744 CHEMBL1475972 CHEMBL1949934 CHEMBL1966661 |
D002762
|
117 / 75 / 80 | 47 / 35 | No. 4779 |
![]() |
|
C00001431
![]() |
Spermidine
|
CHEMBL19612
|
D013095
|
26 / 10 / 12 | 5 / 5 | No. 5867 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000092 C00000094 C00000104 C00000134 C00000575 C00001429 C00001431 C00001434 C00002267 C00004565 C00007233 C00030767 C00041217 | 0 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000092 C00000094 C00000104 C00000134 C00000575 C00001429 C00001431 C00001434 C00002267 C00004565 C00030767 C00041217 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000092 C00000094 C00000104 C00000134 C00000575 C00001429 C00001431 C00001434 C00002267 C00004565 C00030767 C00041217 | 1 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000092 C00000094 C00000104 C00000134 C00000575 C00001429 C00001431 C00001434 C00002267 C00004565 C00030767 C00041217 | 1 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000092 C00000094 C00000104 C00000134 C00001429 C00001431 C00001434 C00002267 C00004565 C00030767 C00041217 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000091 C00000092 C00000104 C00000134 C00000575 C00000805 C00001429 C00001431 C00030767 | 3 / 2 |
O75496 | Geminin | Unclassified protein | C00000092 C00000104 C00000911 C00001434 C00002262 C00007571 C00040805 C00041217 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000104 C00000575 C00002267 C00004565 C00005374 C00007571 C00041217 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000104 C00000911 C00001429 C00001431 C00002262 C00007571 C00041217 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000092 C00000104 C00000911 C00002267 C00004565 C00030767 | 11 / 10 |
O00255 | Menin | Unclassified protein | C00002262 C00003110 C00004565 C00007233 C00007571 C00041217 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002262 C00003110 C00004565 C00007233 C00007571 C00041217 | 1 / 2 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001283 C00001429 C00004565 C00007233 C00030767 C00041217 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000104 C00000911 C00030767 C00040805 C00041217 | 2 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000134 C00000575 C00001434 C00004565 C00041217 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001429 C00004565 C00007233 C00030767 C00041217 | 0 / 3 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00004565 C00007233 C00007571 C00040805 C00041217 | 4 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000104 C00004565 C00007571 C00041217 | 2 / 2 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001434 C00004565 C00005374 C00007571 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001429 C00001434 C00030767 C00041217 | 0 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001429 C00001434 C00030767 C00041217 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001429 C00001431 C00030767 C00041217 | 1 / 2 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00004565 C00005374 C00007233 C00007571 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000134 C00000575 C00004565 C00041217 | 3 / 4 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000575 C00004565 C00005374 C00007571 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000134 C00004565 C00030767 C00041217 | 1 / 1 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002262 C00007571 C00040805 C00041217 | 4 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000911 C00004565 C00040805 C00041217 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00001429 C00004565 C00030767 C00041217 | 1 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000104 C00000575 C00002262 C00007571 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001429 C00001434 C00030767 C00041217 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001429 C00001434 C00030767 C00041217 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000575 C00001434 C00030767 C00041217 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001283 C00030767 C00041217 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00000575 C00007233 C00007571 | 7 / 3 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001431 C00004565 C00007233 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002262 C00004565 C00005374 | 0 / 0 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001429 C00030767 C00041217 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001429 C00030767 C00041217 | 2 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000911 C00005374 C00041217 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00004565 C00030767 C00041217 | 1 / 8 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001431 C00004565 C00041217 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001429 C00030767 C00041217 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000575 C00004565 C00041217 | 3 / 3 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001431 C00001434 C00002262 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00004565 C00030767 C00041217 | 0 / 1 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001429 C00030767 C00041217 | 2 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000805 C00030767 C00041217 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002267 C00030767 C00041217 | 1 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00004565 C00030767 C00041217 | 2 / 2 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00000104 C00001429 C00040805 | 2 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000805 C00004565 C00041217 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00004565 C00005374 C00007233 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00000100 C00000104 C00001151 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001429 C00030767 C00041217 | 1 / 0 |
P15121 | Aldose reductase | Enzyme | C00004565 C00005374 | 0 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00030767 C00041217 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00030767 C00041217 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00030767 C00041217 | 0 / 0 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00001283 C00001429 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00030767 C00041217 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00001429 C00041217 | 5 / 1 |
P28222 | 5-hydroxytryptamine receptor 1B | Serotonin receptor | C00001429 C00001434 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00030767 C00041217 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00030767 C00041217 | 1 / 1 |
P08183 | Multidrug resistance protein 1 | drug | C00000575 C00004565 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00030767 C00041217 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00030767 C00041217 | 0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00000092 C00004565 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00030767 C00041217 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00030767 C00041217 | 0 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00004565 C00041217 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00030767 C00041217 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00004565 C00005374 | 1 / 1 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00030767 C00041217 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00030767 C00041217 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000104 C00001434 | 0 / 0 |
P28221 | 5-hydroxytryptamine receptor 1D | Serotonin receptor | C00001429 C00001434 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00030767 C00041217 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002262 C00007571 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00030767 C00041217 | 2 / 2 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00004565 C00041217 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00030767 C00041217 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00030767 C00041217 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00030767 C00041217 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00030767 C00041217 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00001429 C00001431 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00030767 C00041217 | 0 / 0 |
P05164 | Myeloperoxidase | Enzyme | C00001429 C00001434 | 1 / 2 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00030767 C00041217 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00030767 C00041217 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00030767 C00041217 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00030767 C00041217 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00030767 C00041217 | 1 / 1 |
P17252 | Protein kinase C alpha type | Alpha | C00030767 C00041217 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00030767 C00041217 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00030767 C00041217 | 1 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00001429 C00001431 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00030767 C00041217 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00001429 C00001431 | 1 / 2 |
Q16773 | Kynurenine--oxoglutarate transaminase 1 | Enzyme | C00000100 C00007571 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00030767 C00041217 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00001429 C00001431 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001429 C00001431 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001429 C00001431 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000104 C00002262 | 2 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001429 C00001431 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00004565 C00007233 | 6 / 4 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00030767 C00041217 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00030767 C00041217 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00030767 C00041217 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00030767 C00041217 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00030767 C00041217 | 0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00030767 C00041217 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00030767 C00041217 | 1 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00030767 C00041217 | 0 / 1 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00030767 C00041217 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00030767 C00041217 | 1 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00030767 C00041217 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00030767 C00041217 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00000134 C00041217 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00030767 C00041217 | 1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001429 C00001431 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00030767 C00041217 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00030767 C00041217 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00030767 C00041217 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00030767 C00041217 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00030767 C00041217 | 2 / 1 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00030767 C00041217 | 1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | C00001429 C00001431 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00030767 C00041217 | 0 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00030767 C00041217 | 0 / 1 |
Q99700 | Ataxin-2 | Unclassified protein | C00002262 C00004565 | 1 / 1 |
Q9Y253 | DNA polymerase eta | Enzyme | C00004565 C00005374 | 1 / 1 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00000998 C00004565 | 2 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00030767 C00041217 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00001429 C00001431 | 1 / 1 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000091 C00001429 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00004565 C00041217 | 7 / 37 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00030767 C00041217 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00030767 C00041217 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00001429 C00001431 | 0 / 1 |
P14679 | Tyrosinase | Oxidoreductase | C00001429 C00004565 | 4 / 2 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00030767 C00041217 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00001429 C00041217 | 3 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00004565 C00041217 | 5 / 3 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00030767 C00041217 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00030767 C00041217 | 1 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00004565 C00041217 | 1 / 1 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00030767 C00041217 | 2 / 1 |
P21452 | Substance-K receptor | Neurokinin receptor | C00030767 C00041217 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00005374 C00007233 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00030767 C00041217 | 1 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00030767 C00041217 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00030767 C00041217 | 3 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00030767 C00041217 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00004565 C00041217 | 0 / 0 |
Q15125 | 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | Enzyme | C00002267 | 1 / 1 |
P04745 | Alpha-amylase 1 | Enzyme | C00004565 | 0 / 0 |
P48039 | Melatonin receptor type 1A | Melatonin receptor | C00001429 | 0 / 0 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00001429 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00004565 | 0 / 0 |
P30304 | M-phase inducer phosphatase 1 | Ser_Thr_Tyr | C00041217 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00004565 | 4 / 4 |
P56817 | Beta-secretase 1 | A1A | C00000575 | 0 / 0 |
Q9HBH1 | Peptide deformylase, mitochondrial | Enzyme | C00000100 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00026660 | 2 / 2 |
Q99816 | Tumor susceptibility gene 101 protein | Unclassified protein | C00002262 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00005374 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00000104 | 1 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000104 | 5 / 2 |
Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | C00004565 | 1 / 1 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00004565 | 0 / 1 |
P06133 | UDP-glucuronosyltransferase 2B4 | Enzyme | C00001429 | 0 / 0 |
P07711 | Cathepsin L1 | C1A | C00040805 | 0 / 0 |
Q6QHF9 | Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | Enzyme | C00001431 | 0 / 0 |
P46098 | 5-hydroxytryptamine receptor 3A | NS | C00001429 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00001429 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00004565 | 0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00004565 | 1 / 1 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00004565 | 0 / 0 |
P28566 | 5-hydroxytryptamine receptor 1E | Serotonin receptor | C00001429 | 0 / 0 |
P16389 | Potassium voltage-gated channel subfamily A member 2 | KCNA, Kv1.x (Shaker) | C00000575 | 0 / 0 |
P43235 | Cathepsin K | C1A | C00001434 | 1 / 2 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00004565 | 0 / 0 |
Q9GZU7 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Enzyme | C00004565 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001434 | 1 / 0 |
P07237 | Protein disulfide-isomerase | Enzyme | C00005374 | 0 / 0 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00004565 | 0 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00004565 | 0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00004565 | 0 / 0 |
P98170 | E3 ubiquitin-protein ligase XIAP | Other cytosolic protein | C00004565 | 1 / 1 |
P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | C00001429 | 0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00000104 | 1 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00004565 | 0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00004565 | 0 / 0 |
P47898 | 5-hydroxytryptamine receptor 5A | Serotonin receptor | C00001429 | 0 / 0 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00004565 | 1 / 0 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00000104 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00001429 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00041217 | 3 / 1 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00001429 | 1 / 0 |
P23415 | Glycine receptor subunit alpha-1 | GLR alpha | C00001429 | 1 / 1 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002267 | 0 / 0 |
P17658 | Potassium voltage-gated channel subfamily A member 6 | K | C00000575 | 0 / 0 |
P20813 | Cytochrome P450 2B6 | Cytochrome P450 2B6 | C00000575 | 1 / 0 |
P49286 | Melatonin receptor type 1B | Melatonin receptor | C00001429 | 0 / 1 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00004565 | 0 / 0 |
P22001 | Potassium voltage-gated channel subfamily A member 3 | KCNA, Kv1.x (Shaker) | C00000575 | 0 / 0 |
Q13639 | 5-hydroxytryptamine receptor 4 | Serotonin receptor | C00001429 | 0 / 0 |
P30939 | 5-hydroxytryptamine receptor 1F | Serotonin receptor | C00001429 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00004565 | 0 / 0 |
Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | Unclassified protein | C00001429 | 0 / 0 |
P22460 | Potassium voltage-gated channel subfamily A member 5 | KCNA, Kv1.x (Shaker) | C00000575 | 1 / 1 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00004565 | 0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00004565 | 0 / 0 |
O15244 | Solute carrier family 22 member 2 | Drug uniporter | C00001429 | 0 / 0 |
P48147 | Prolyl endopeptidase | S9A | C00004565 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00007571 | 0 / 0 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | C00004565 | 0 / 0 |
Q99835 | Smoothened homolog | Smoothened receptor (frizzled family GPCR) | C00041217 | 0 / 1 |
P48547 | Potassium voltage-gated channel subfamily C member 1 | K | C00000575 | 0 / 0 |
O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | C00001429 | 1 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00001431 | 1 / 1 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00005374 | 0 / 0 |
Q09470 | Potassium voltage-gated channel subfamily A member 1 | KCNA, Kv1.x (Shaker) | C00000575 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00000104 | 1 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00004565 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00004565 | 0 / 0 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001429 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001429 | 1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001429 | 1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001429 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001429 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001429 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001429 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001429 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001429 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001429 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001429 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001429 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001429 | 4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001429 | 0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001429 | 0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001429 | 1 / 0 |
Q9UBF8 | Phosphatidylinositol 4-kinase beta | Enzyme | C00000092 | 0 / 0 |
Q8TCG2 | Phosphatidylinositol 4-kinase type 2-beta | Enzyme | C00000092 | 0 / 0 |
Q9BTU6 | Phosphatidylinositol 4-kinase type 2-alpha | Enzyme | C00000092 | 0 / 0 |
P42356 | Phosphatidylinositol 4-kinase alpha | Enzyme | C00000092 | 0 / 0 |
Q9H015 | Solute carrier family 22 member 4 | Unclassified protein | C00001431 | 1 / 1 |
O75751 | Solute carrier family 22 member 3 | Unclassified protein | C00001429 | 0 / 0 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00004565 | 0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00004565 | 0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00004565 | 0 / 0 |
Q8WXA8 | 5-hydroxytryptamine receptor 3C | NS | C00001429 | 0 / 0 |
Q70Z44 | 5-hydroxytryptamine receptor 3D | NS | C00001429 | 0 / 0 |
O95264 | 5-hydroxytryptamine receptor 3B | NS | C00001429 | 0 / 0 |
A5X5Y0 | 5-hydroxytryptamine receptor 3E | NS | C00001429 | 0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00004565 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00004565 | 0 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001431 | 0 / 0 |
P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00002262 | 0 / 3 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00004565 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000911
C00001429
C00004565
C00030767
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000911
C00004565
C00041217
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000911
C00004565
C00030767
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000911
C00004565
C00041217
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001429
C00004565
C00041217
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000100
C00000911
C00004565
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00000911
C00004565
|
6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00001429
C00001434
|
3356 | HTR2A, 5-HT2A, HTR2 | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
C00001429
C00001434
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000911
C00041217
|
898 | CCNE1, CCNE | cyclin E1 |
C00000911
C00041217
|
847 | CAT | catalase (EC:1.11.1.6) |
C00000911
C00001429
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00004565
C00030767
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00004565
C00030767
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00004565
C00030767
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00004565
C00030767
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000911
C00004565
|
7431 | VIM, CTRCT30 | vimentin |
C00000094
C00041217
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000094
C00030767
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00000911
C00004565
|
6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00001429
C00001434
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000911
C00004565
|
6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00001429
C00001434
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00000100
C00004565
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000911
C00004565
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000911
C00004565
|
134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00001429
C00001434
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00004565
C00041217
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00004565
C00041217
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001431
C00004565
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00004565
C00041217
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00001429
C00004565
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000911
C00004565
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00000911
C00004565
|
1591 | CYP24A1, CP24, CYP24, HCAI, P450-CC24 | cytochrome P450, family 24, subfamily A, polypeptide 1 (EC:1.14.13.126) |
C00040805
C00041217
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00004565
C00030767
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001429
C00004565
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00000911
C00004565
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000911
C00004565
|
7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00040805
C00041217
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001429
C00041217
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00004565
C00041217
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00004565
C00005374
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00004565
C00005374
|
6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00041217
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00004565
|
37618 |
C00004565
|
||
1734 | DIO2, 5DII, D2, DIOII, SelY, TXDI2 | deiodinase, iodothyronine, type II (EC:1.97.1.10) |
C00004565
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00004565
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00004565
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00004565
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00004565
|
4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00004565
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00004565
|
9687 | GREB1 | growth regulation by estrogen in breast cancer 1 |
C00004565
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00004565
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00004565
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00004565
|
3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00004565
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00004565
|
891 | CCNB1, CCNB | cyclin B1 |
C00004565
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00004565
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00004565
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00004565
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00004565
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00004565
|
4297 | KMT2A, ALL-1, CXXC7, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TET1-MLL, TRX1, WDSTS | lysine (K)-specific methyltransferase 2A (EC:2.1.1.43) |
C00004565
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00004565
|
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00004565
|
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00004565
|
110357 |
C00004565
|
||
4502 | MT2A, MT2 | metallothionein 2A |
C00004565
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00004565
|
8202 | NCOA3, ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | nuclear receptor coactivator 3 (EC:2.3.1.48) |
C00004565
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00004565
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00004565
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00004565
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00004565
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00004565
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00004565
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00004565
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00004565
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00004565
|
6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00004565
|
2810 | SFN, YWHAS | stratifin |
C00004565
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00004565
|
6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00004565
|
7019 | TFAM, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2, TCF6L3 | transcription factor A, mitochondrial |
C00004565
|
239 | ALOX12, 12-LOX, 12S-LOX, LOG12 | arachidonate 12-lipoxygenase (EC:1.13.11.31) |
C00004565
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00004565
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00004565
|
440 | ASNS, TS11 | asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) |
C00000094
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00004565
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00004565
|
7161 | TP73, P73 | tumor protein p73 |
C00004565
|
7352 | UCP3, SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) |
C00004565
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00004565
|
7127 | TNFAIP2, B94, EXOC3L3 | tumor necrosis factor, alpha-induced protein 2 |
C00000094
|
7029 | TFDP2, DP2 | transcription factor Dp-2 (E2F dimerization partner 2) |
C00000094
|
6286 | S100P, MIG9 | S100 calcium binding protein P |
C00000094
|
6016 | RIT1, NS8, RIBB, RIT, ROC1 | Ras-like without CAAX 1 |
C00000094
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00004565
|
7402 | UTRN, DMDL, DRP, DRP1 | utrophin |
C00004565
|
8839 | WISP2, CCN5, CT58, CTGF-L | WNT1 inducible signaling pathway protein 2 |
C00004565
|
118 | ADD1, ADDA | adducin 1 (alpha) |
C00000911
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00000911
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000911
|
571 | BACH1, BACH-1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
C00000911
|
8314 | BAP1, HUCEP-13, UCHL2 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12) |
C00000911
|
673 | BRAF, B-RAF1, BRAF1, NS7, RAFB1 | v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) |
C00000911
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000911
|
6004 | RGS16, A28-RGS14, A28-RGS14P, RGS-R | regulator of G-protein signaling 16 |
C00000094
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000911
|
5774 | PTPN3, PTP-H1, PTPH1 | protein tyrosine phosphatase, non-receptor type 3 (EC:3.1.3.48) |
C00000094
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00000911
|
1020 | CDK5, PSSALRE | cyclin-dependent kinase 5 (EC:2.7.11.22) |
C00000911
|
1022 | CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15 | cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1025 | CDK9, C-2k, CDC2L4, CTK1, PITALRE, TAK | cyclin-dependent kinase 9 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
1113 | CHGA, CGA | chromogranin A (parathyroid secretory protein 1) |
C00000911
|
1114 | CHGB, SCG1 | chromogranin B (secretogranin 1) |
C00000911
|
23418 | CRB1, LCA8, RP12 | crumbs homolog 1 (Drosophila) |
C00000911
|
1643 | DDB2, DDBB, UV-DDB2 | damage-specific DNA binding protein 2, 48kDa |
C00000911
|
1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 |
C00000911
|
2176 | FANCC, FA3, FAC, FACC | Fanconi anemia, complementation group C |
C00000911
|
2188 | FANCF, FAF | Fanconi anemia, complementation group F |
C00000911
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00000911
|
2701 | GJA4, CX37 | gap junction protein, alpha 4, 37kDa |
C00000911
|
2702 | GJA5, ATFB11, CX40 | gap junction protein, alpha 5, 40kDa |
C00000911
|
2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) |
C00000911
|
3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00000911
|
3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00000911
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00000911
|
3485 | IGFBP2, IBP2, IGF-BP53 | insulin-like growth factor binding protein 2, 36kDa |
C00000911
|
3713 | IVL | involucrin |
C00000911
|
3716 | JAK1, JAK1A, JAK1B, JTK3 | Janus kinase 1 (EC:2.7.10.2) |
C00000911
|
3796 | KIF2A, CDCBM3, HK2, KIF2 | kinesin heavy chain member 2A |
C00000911
|
3838 | KPNA2, IPOA1, QIP2, RCH1, SRP1alpha | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
C00000911
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00000911
|
3988 | LIPA, CESD, LAL | lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
C00000911
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00000911
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00000911
|
6416 | MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1 | mitogen-activated protein kinase kinase 4 (EC:2.7.12.2) |
C00000911
|
5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) |
C00000911
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00000911
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000911
|
4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) |
C00000911
|
100507436 | MICA, MIC-A, PERB11.1 | MHC class I polypeptide-related sequence A |
C00000911
|
4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00000911
|
4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00000911
|
2956 | MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160 | mutS homolog 6 |
C00000911
|
4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00000911
|
8021 | NUP214, CAIN, CAN, D9S46E, N214, p250 | nucleoporin 214kDa |
C00000911
|
5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00000911
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00000911
|
10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00000911
|
8045 | RASSF7, C11orf13, HRAS1, HRC1 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
C00000911
|
5782 | PTPN12, PTP-PEST, PTPG1 | protein tyrosine phosphatase, non-receptor type 12 (EC:3.1.3.48) |
C00000094
|
5962 | RDX, DFNB24 | radixin |
C00000911
|
6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) |
C00000911
|
6197 | RPS6KA3, CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RSK2, S6K-alpha3, p90-RSK2, pp90RSK2 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1) |
C00000911
|
6241 | RRM2, R2, RR2, RR2M | ribonucleotide reductase M2 (EC:1.17.4.1) |
C00000911
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00000911
|
6414 | SEPP1, SELP, SeP | selenoprotein P, plasma, 1 |
C00000911
|
4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00000911
|
8243 | SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB | structural maintenance of chromosomes 1A |
C00000911
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00000911
|
7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00000911
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00000911
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000911
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000911
|
7415 | VCP, ALS14, IBMPFD, IBMPFD1, TERA, p97 | valosin containing protein (EC:3.6.4.6) |
C00000911
|
7485 | WRB, CHD5 | tryptophan rich basic protein |
C00000911
|
7697 | ZNF138, pHZ-32 | zinc finger protein 138 |
C00000911
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00001434
|
9360 | PPIG, CARS-Cyp, CYP, SCAF10, SRCyp | peptidylprolyl isomerase G (cyclophilin G) (EC:5.2.1.8) |
C00000094
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00000094
|
8544 | PIR | pirin (iron-binding nuclear protein) (EC:1.13.11.24) |
C00000094
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00000094
|
9818 | NUPL1, PRO2463 | nucleoporin like 1 |
C00000094
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00030767
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00030767
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00030767
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00030767
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00030767
|
2010 | EMD, EDMD, LEMD5, STA | emerin |
C00030767
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00030767
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00030767
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00030767
|
9514 | GAL3ST1, CST | galactose-3-O-sulfotransferase 1 (EC:2.8.2.11) |
C00030767
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00030767
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00030767
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00030767
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00030767
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00030767
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00030767
|
4883 | NPR3, ANP-C, ANPR-C, ANPRC, C5orf23, GUCY2B, NPR-C, NPRC | natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
C00030767
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00030767
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00030767
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00030767
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00030767
|
182 | JAG1, AGS, AHD, AWS, CD339, HJ1, JAGL1 | jagged 1 |
C00000094
|
1594 | CYP27B1, CP2B, CYP1, CYP1alpha, CYP27B, P450c1, PDDR, VDD1, VDDR, VDDRI, VDR | cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13) |
C00040805
|
10681 | GNB5, GB5 | guanine nucleotide binding protein (G protein), beta 5 |
C00000094
|
10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00041217
|
572 | BAD, BBC2, BCL2L8 | BCL2-associated agonist of cell death |
C00041217
|
8678 | BECN1, ATG6, VPS30, beclin1 | beclin 1, autophagy related |
C00041217
|
632 | BGLAP, BGP, OC, OCN | bone gamma-carboxyglutamate (gla) protein |
C00041217
|
929 | CD14 | CD14 molecule |
C00041217
|
978 | CDA, CDD | cytidine deaminase (EC:3.5.4.5) |
C00041217
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00041217
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00041217
|
1032 | CDKN2D, INK4D, p19, p19-INK4D | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
C00041217
|
1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00041217
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00041217
|
1577 | CYP3A5, CP35, CYPIIIA5, P450PCN3, PCN3 | cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1) |
C00041217
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00041217
|
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00041217
|
3684 | ITGAM, CD11B, CR3A, MAC-1, MAC1A, MO1A, SLEB6 | integrin, alpha M (complement component 3 receptor 3 subunit) |
C00041217
|
3687 | ITGAX, CD11C, SLEB6 | integrin, alpha X (complement component 3 receptor 4 subunit) |
C00041217
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00041217
|
2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00041217
|
4538 | ND4, MTND4, MT-ND4 | NADH dehydrogenase, subunit 4 (complex I) |
C00041217
|
694 | BTG1 | B-cell translocation gene 1, anti-proliferative |
C00000094
|
5289 | PIK3C3, VPS34, hVps34 | phosphatidylinositol 3-kinase, catalytic subunit type 3 (EC:2.7.1.137) |
C00041217
|
5371 | PML, MYL, PP8675, RNF71, TRIM19 | promyelocytic leukemia |
C00041217
|
5741 | PTH, PTH1 | parathyroid hormone |
C00041217
|
5829 | PXN | paxillin |
C00041217
|
5894 | RAF1, CRAF, NS5, Raf-1, c-Raf | v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) |
C00041217
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00041217
|
6198 | RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha | ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) |
C00041217
|
860 | RUNX2, AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD, OSF-2, OSF2, PEA2aA, PEBP2aA | runt-related transcription factor 2 |
C00041217
|
6678 | SPARC, ON | secreted protein, acidic, cysteine-rich (osteonectin) |
C00041217
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00004565
|
6901 | TAZ, BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX, Taz1 | tafazzin |
C00041217
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00041217
|
4982 | TNFRSF11B, OCIF, OPG, TR1 | tumor necrosis factor receptor superfamily, member 11b |
C00041217
|
8600 | TNFSF11, CD254, ODF, OPGL, OPTB2, RANKL, TRANCE, hRANKL2, sOdf | tumor necrosis factor (ligand) superfamily, member 11 |
C00041217
|
10628 | TXNIP, EST01027, HHCPA78, THIF, VDUP1 | thioredoxin interacting protein |
C00041217
|
2597 | GAPDH, G3PD, GAPD | glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12) |
C00001429
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00001429
|
3352 | HTR1D, 5-HT1D, HT1DA, HTR1DA, HTRL, RDC4 | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
C00001429
|
3359 | HTR3A, 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3 | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
C00001429
|
9177 | HTR3B, 5-HT3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
C00001429
|
3363 | HTR7, 5-HT7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
C00001429
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00001429
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001429
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00001429
|
4128 | MAOA, MAO-A | monoamine oxidase A (EC:1.4.3.4) |
C00001429
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00001429
|
6570 | SLC18A1, CGAT, VAT1, VMAT1 | solute carrier family 18 (vesicular monoamine transporter), member 1 |
C00001429
|
6571 | SLC18A2, SVAT, SVMT, VAT2, VMAT2 | solute carrier family 18 (vesicular monoamine transporter), member 2 |
C00001429
|
85413 | SLC22A16, CT2, FLIPT2, OAT6, OCT6, OKB1, dJ261K5.1 | solute carrier family 22 (organic cation/carnitine transporter), member 16 |
C00001429
|
6814 | STXBP3, MUNC18-3, MUNC18C, PSP, UNC-18C | syntaxin binding protein 3 |
C00001429
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00001429
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00001429
|
7166 | TPH1, TPRH, TRPH, TPH | tryptophan hydroxylase 1 (EC:1.14.16.4) |
C00001429
|
8989 | TRPA1, ANKTM1, FEPS | transient receptor potential cation channel, subfamily A, member 1 |
C00001429
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00001429
|
7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00001429
|
153 | ADRB1, ADRB1R, B1AR, BETA1AR, RHR | adrenoceptor beta 1 |
C00001431
|
154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00001431
|
486 | FXYD2, ATP1G1, HOMG2 | FXYD domain containing ion transport regulator 2 |
C00001431
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00001431
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001151
|
55630 | SLC39A4, AEZ, AWMS2, ZIP4 | solute carrier family 39 (zinc transporter), member 4 |
C00001151
|
80834 | TAS1R2, GPR71, T1R2, TR2 | taste receptor, type 1, member 2 |
C00001151
|
83756 | TAS1R3, T1R3 | taste receptor, type 1, member 3 |
C00001151
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 P47869 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#612240 | Atrial fibrillation, familial, 7; atfb7 |
P22460
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#302960 | Chondrodysplasia punctata 2, x-linked dominant; cdpx2 |
Q15125
|
#114500 | Colorectal cancer; crc |
P84022
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#614546 | Efavirenz, poor metabolism of |
P20813
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#160120 | Episodic ataxia, type 1; ea1 |
Q09470
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#149400 | Hyperekplexia, hereditary 1; hkpx1 |
P23415
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#300635 | Lymphoproliferative syndrome, x-linked, 2; xlp2 |
P98170
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#254600 | Myeloperoxidase deficiency; mpod |
P05164
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#265800 | Pycnodysostosis |
P43235
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#180300 | Rheumatoid arthritis; ra |
Q9H015
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
H00082 | Graves' disease |
P01215
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
P16473 (related) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P27487 (marker) P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
Q99835 (related) |
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00101 | Other phagocyte defects |
P05164
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P05164
(marker)
P36888 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00731 | Atrial fibrillation |
P22460
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H00769 | Hyperekplexia |
P23415
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
P49286 (related) |
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00273 | Pycnodysostosis |
P43235
(related)
|
H00425 | Lysosomal cysteine protease deficiencies |
P43235
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P98170
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00749 | Episodic ataxias |
Q09470
(related)
|
H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H01194 | X-linked chondrodysplasia punctata |
Q15125
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00286 | Crohn's disease |
Q9H015
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D006973 | Hypertension |
C00041217
C00000104 C00001429 C00001151 |
D012640 | Seizures |
C00001434
C00000104 C00001429 C00001431 |
D011471 | Prostatic Neoplasms |
C00000911
C00040805 C00041217 |
D009135 | Muscular Diseases |
C00030767
C00040805 C00001429 |
D056486 | Drug-Induced Liver Injury |
C00000911
C00000100 C00001431 |
D010146 | Pain |
C00005374
C00001429 |
D006332 | Cardiomegaly |
C00041217
C00001431 |
D010018 | Osteomalacia |
C00040805
C00041217 |
D006934 | Hypercalcemia |
C00040805
C00041217 |
D006943 | Hyperglycemia |
C00004565
C00000911 |
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00041217
C00000104 |
D006965 | Hyperplasia |
C00000911
C00041217 |
D009336 | Necrosis |
C00030767
C00001429 |
D007249 | Inflammation |
C00000911
C00001429 |
D050197 | Atherosclerosis |
C00004565
C00041217 |
D014202 | Tremor |
C00001434
C00001429 |
D013226 | Status Epilepticus |
C00000104
C00001429 |
D006948 | Hyperkinesis |
C00001431
C00001151 |
D015431 | Weight Loss |
C00000911
C00041217 |
D004487 | Edema |
C00001429
|
D014178 | Translocation, Genetic |
C00000911
|
D012878 | Skin Neoplasms |
C00000911
|
D006505 | Hepatitis |
C00000575
|
D010787 | Photosensitivity Disorders |
C00000575
|
D011565 | Psoriasis |
C00000575
|
D020258 | Neurotoxicity Syndromes |
C00000911
|
D009369 | Neoplasms |
C00000911
|
D007674 | Kidney Diseases |
C00000911
|
D007248 | Infertility, Male |
C00000911
|
D009395 | Nephritis, Interstitial |
C00030767
|
D011297 | Prenatal Exposure Delayed Effects |
C00004565
|
D010024 | Osteoporosis |
C00004565
|
D012080 | Renal Osteodystrophy |
C00040805
|
D058186 | Acute Kidney Injury |
C00041217
|
D000307 | Adrenal Gland Diseases |
C00041217
|
D001018 | Aortic Diseases |
C00041217
|
D001161 | Arteriosclerosis |
C00041217
|
D001327 | Autoimmune Diseases |
C00041217
|
D002114 | Calcinosis |
C00041217
|
D007938 | Leukemia |
C00004565
|
D015362 | Child Nutrition Disorders |
C00041217
|
D003324 | Coronary Artery Disease |
C00041217
|
D004342 | Drug Hypersensitivity |
C00041217
|
D002318 | Cardiovascular Diseases |
C00004565
|
D005767 | Gastrointestinal Diseases |
C00041217
|
D006130 | Growth Disorders |
C00041217
|
D053565 | Hypercalciuria |
C00041217
|
D054559 | Hyperphosphatemia |
C00041217
|
D009202 | Cardiomyopathies |
C00004565
|
D006996 | Hypocalcemia |
C00041217
|
D020347 | Lithiasis |
C00041217
|
D008325 | Mammary Neoplasms, Experimental |
C00041217
|
D009120 | Muscle Cramp |
C00041217
|
D009123 | Muscle Hypotonia |
C00041217
|
D010673 | Pheochromocytoma |
C00041217
|
D017285 | Polymyositis |
C00041217
|
D051437 | Renal Insufficiency |
C00041217
|
D012279 | Rickets |
C00041217
|
D013971 | THYROTOXICOSIS |
C00041217
|
D061205 | Vascular Calcification |
C00041217
|
D014652 | Vascular Diseases |
C00041217
|
D014808 | Vitamin D Deficiency |
C00041217
|
D000987 | Antisocial Personality Disorder |
C00000104
|
D001927 | Brain Diseases |
C00000104
|
D005391 | Firesetting Behavior |
C00000104
|
D007174 | Impulse Control Disorders |
C00000104
|
D001943 | Breast Neoplasms |
C00004565
|
D000544 | Alzheimer Disease |
C00001429
|
D000648 | Amnesia, Retrograde |
C00001429
|
D001008 | Anxiety Disorders |
C00001429
|
D001022 | Aortic Valve Insufficiency |
C00001429
|
D001049 | Apnea |
C00001429
|
D001281 | Atrial Fibrillation |
C00001429
|
D001321 | Autistic Disorder |
C00001429
|
D001919 | Bradycardia |
C00001429
|
D002375 | Catalepsy |
C00001429
|
D002389 | Catatonia |
C00001429
|
D002659 | Child Development Disorders, Pervasive |
C00001429
|
D021081 | Chronobiology Disorders |
C00001429
|
D015140 | Dementia, Vascular |
C00001429
|
D003967 | Diarrhea |
C00001429
|
D004195 | Disease Models, Animal |
C00001429
|
D013733 | Testicular Diseases |
C00000911
|
D005355 | Fibrosis |
C00001429
|
D005483 | Flushing |
C00001429
|
D006349 | Heart Valve Diseases |
C00001429
|
D006930 | Hyperalgesia |
C00001429
|
D006976 | Hypertension, Pulmonary |
C00001429
|
D017379 | Hypertrophy, Left Ventricular |
C00001429
|
D007022 | Hypotension |
C00001429
|
D043183 | Irritable Bowel Syndrome |
C00001429
|
D008944 | Mitral Valve Insufficiency |
C00001429
|
D009422 | Nervous System Diseases |
C00001429
|
D011537 | Pruritus |
C00001429
|
D020230 | Serotonin Syndrome |
C00001429
|
D013276 | Stomach Ulcer |
C00001429
|
D020521 | Stroke |
C00001429
|
D013610 | Tachycardia |
C00001429
|
D059246 | Tachypnea |
C00001429
|
D003877 | Dermatitis, Contact |
C00000805
|
D011041 | Poisoning |
C00001431
|
D019969 | Amphetamine-Related Disorders |
C00001151
|
D018149 | Glucose Intolerance |
C00001151
|
D006461 | Hemolysis |
C00001151
|
D006946 | Hyperinsulinism |
C00001151
|
D007333 | Insulin Resistance |
C00001151
|
D009401 | Nephrosis |
C00001151
|
C541083 | Non-alcoholic Fatty Liver Disease |
C00001151
|
D019966 | Substance-Related Disorders |
C00001151
|
D000647 | Amnesia |
C00000091
|